Twelve-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin for non-cirrhotic HCV genotype 1 patients: A phase 2 study

Jia Horng Kao, Min Lung Yu, Chi Yi Chen, Cheng Yuan Peng, Ming Yao Chen, Huoling Tang, Qiaoqiao Chen, Jinzi J. Wu

研究成果: 雜誌貢獻文章同行評審

11 引文 斯高帕斯(Scopus)

指紋

深入研究「Twelve-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin for non-cirrhotic HCV genotype 1 patients: A phase 2 study」主題。共同形成了獨特的指紋。

Medicine & Life Sciences